Next Financial Group’s Puma Biotechnology PBYI Stock Holding History

Next Financial Group’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$5K	–	2061
2018 Q3	$5K	Buy	+100	New	+$4.82K	﹤0.01%	1165

Other funds holding PBYI

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Next Financial Group's PBYI Position: Q4 2018 in Review

Next Financial Group sold out of Puma Biotechnology (PBYI) in Q4 2018, closing a stake of 100 shares — an estimated $5K sold.

Next Financial Group first reported a position in PBYI in Q3 2018 and held it in 1 quarter. The position peaked at $5K in Q3 2018. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

Next Financial Group reported no remaining Puma Biotechnology position as of Q4 2018 after selling out during the quarter.
Next Financial Group sold 100 Puma Biotechnology shares in Q4 2018, an estimated $5K.
Next Financial Group first reported a position in Puma Biotechnology in Q3 2018 and held it in 1 quarter.
Next Financial Group's Puma Biotechnology position peaked at $5K in Q3 2018.
141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Next Financial Group's 13F filing for Q4 2018, filed 11 Feb 2019.